跳至主要内容
临床试验/NCT05565339
NCT05565339已完成不适用

PMEI Post-Market Clinical Follow-Up

MED-EL Elektromedizinische Geräte GesmbH11 个研究点 分布在 3 个国家目标入组 497 人开始时间: 2020年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
497
试验地点
11
主要终点
ABG

研究概览

简要总结

Confirm safety and performance of passive middle ear implants (PMEIs) in subjects with pre-existing condition which made the implantation of a MED-EL PMEI necessary

详细描述

Collect retrospective audiological and safety results of PMEI implanted subjects. A post-operative minimum and maximum follow-up period was not defined. The mean of the post-operative follow-up period of all patients was calculated.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
0 Years 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Implanted with a MED-EL PMEI; initial implantation or revision implantation receiving a MED-EL PMEI

排除标准

  • 未提供

结局指标

主要结局

ABG

时间窗: A post-operative minimum and maximum follow-up period was not defined.

To collect post-operative PTA4 ABG results. It was expected to achieve a post-operative ABG ≤ 20 dB with a PMEI, by at least 25 % of the total ossicular replacement prostheses patients, by at least 53.8 % of the partial ossicular replacement prostheses patients, and by at least 86 % of the stapes prostheses patients.

次要结局

  • adverse events(A post-operative minimum and maximum follow-up period was not defined.)

研究者

发起方
MED-EL Elektromedizinische Geräte GesmbH
申办方类型
Industry
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验